ArticleThe Journal of infectious diseases2015

Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal.

Elise M O'Connell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.